On November 16, Gelonghui Pharmaceutical (603811.SH) stated at the performance briefing that EPA generic drugs are currently in the acceptance stage, and it is expected that the normal approval time will be about one year. Currently, fish oil softgels from companies such as Shengdi Pharmaceutical and Colon Pharmaceutical have already been declared. Compared with competing products, Chengyi Pharmaceutical has the advantage of integrating API formulations in the EPA field. In terms of overall industry layout, we strive to become the manufacturer with the largest domestic production capacity and the most complete industrial chain.
诚意药业(603811.SH)：目前EPA仿制药在受理阶段，预计正常获批时间为一年左右
Sincerity Pharmaceutical (603811.SH): Currently, EPA generic drugs are in the acceptance stage, and the normal approval time is expected to be about one year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.